This Article Full Text (PDF) All Versions of this Article: 0960327109350666v1 28/11/715    most recent References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Arendse, R. Articles by Irusen, E. PubMed PubMed Citation Articles by Arendse, R. Articles by Irusen, E. Social Bookmarking                         What's this?

An atropine and glycopyrrolate combination reduces mortality in organophosphate poisoning

Rheumatology Unit, Groote Schuur Hospital, and Department of Medicine, University of Cape Town, South Africa, regan{at}arendse.biz

Elvis Irusen

Lung Unit, Tygerberg Academic Hospital and Department of Internal Medicine, University of Stellenbosch, South Africa

Anticholinergics are the mainstay of the pharmacological management of organophosphate poisoning (OPP). Atropine has the potential to cause central toxicity which may complicate the management of this life-threatening condition. A combination of atropine and glycopyrrolate in equivalent dosages titrated to the peripheral muscarinic signs, theoretically reduces the central effect of the anticholinergics by 50% and thereby the risk of central toxicity, while it provides effective control of the peripheral manifestations of OPP. This study reports the clinical morbidity and mortality associated with the management of OP with this anticholinergic combination over a 4-year period, 2003 to 2006, at Tygerberg Academic Hospital (TAH). Two of the 53 patients treated for OPP died, with this mortality lower than that previously reported at TAH. Atropine toxicity was evident in 12 (22.5%) patients and responded to a temporary cessation of the combination infusion. The demographic profile, presenting symptoms, duration of stay and complications encountered were similar to previous reports from TAH. Patients treated with the infusion of a combination of atropine and glycopyrrolate had a lower mortality rate compared with earlier reports from the same unit, but the occurrence of atropine toxicity was unchanged despite the hypothesized theoretical advantage.

Key Words: Atropine • glycopyrrolate • organophosphate poisoning • mortality • toxicity • anticholinergics

This version was published on November 1, 2009

Human & Experimental Toxicology, Vol. 28, No. 11, 715-720 (2009)
DOI: 10.1177/0960327109350666


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?